Differential heat shock protein localization in chronic lymphocytic leukemia

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Mechanisms of carcinogenesis and treatment resistance in cancer are not fully understood.
• Major stress proteins, including heat shock proteins (Hsp72, Hsp90, Hsp27), are overexpressed in many cancers and implicated in resistance.
• Hsp72 can be located intracellularly, conferring apoptosis resistance, and extracellularly on cancer cell membranes.

Purpose of the Study:

• To investigate the localization and expression levels of Hsp72, Hsp90, and Hsp27 in leukocytes of Chronic Lymphocytic Leukemia (CLL) patients.
• To correlate Hsp expression with disease stage, apoptosis markers, and treatment in CLL patients.

Main Methods:

• Flow cytometry was used to quantify intracellular (iHsp) and surface (sHsp) heat shock proteins in leukocytes.
• Analysis included CD5(+)/CD19(+) cells, serum extracellular Hsp72, active caspase-3 levels, and regulatory T cell (Treg) counts.
• Comparison was made between CLL patients and age-matched healthy controls.

Main Results:

• CLL patients exhibited significantly higher intracellular Hsp90 and Hsp27 levels in lymphocytes compared to controls.
• Intracellular Hsp90 expression correlated with disease stage, and intracellular Hsp27 correlated with active caspase-3 levels.
• Extracellular Hsp72 levels in serum correlated with intracellular Hsp72 and were lower in patients on corticosteroid treatment; elevated Tregs were observed in CLL patients.

Conclusions:

• Heat shock proteins Hsp90 and Hsp27 are upregulated in CLL leukocytes and associated with disease characteristics.
• Extracellular Hsp72 levels and Treg numbers may serve as potential biomarkers in CLL.
• Further research into Hsp roles could reveal new therapeutic strategies for CLL.